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We examined how aromatherapy massage influenced psychologic and immunologic parameters
in 12 breast cancer patients in an open semi-comparative trial. We compared the results
1 month before aromatherapy massage as a waiting control period with those during
aromatherapy massage treatment and 1 month after the completion of aromatherapy sessions.
The patients received a 30min aromatherapy massage twice a week for 4 weeks (eight times in
total). The results showed that anxiety was reduced in one 30min aromatherapy massage in
State-Trait Anxiety Inventory (STAI) test and also reduced in eight sequential aromatherapy
massage sessions in the Hospital Anxiety and Depression Scale (HADS) test. Our results
further suggested that aromatherapy massage ameliorated the immunologic state. Further
investigations are required to confirm the anxiolytic effect of aromatherapy in breast cancer
patients.
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Introduction
Aromatherapy is one of the complementary and alter-
native medicines used to treat various diseases and
symptoms, because essential oils have many kinds of
pharmacologic actions including anti-microbial, sedative,
analgesic, spasmolytic and estrogen or steroid hormone-
like effects, etc. Since various kinds of essential oils
such as true lavender, rose, mandarin, sweet orange,
sandalwood, geranium, etc have anxiolytic activity,
aromatherapy has been used for the relief of depression
and anxiety. We have clarified that aromatherapy
massage reduced anxiety and depression in healthy
subjects and that it increased CD8-positive and CD16-
positive lymphocytes in peripheral blood (1).
Furthermore, we found that aromatherapy massage
improved mild depression (2). Patients with cancer tend
to be very anxious about the recurrence of cancer, even
after complete remission. This anxiety in turn might
reduce immunologic activity, resulting in an increase in
the probability of recurrence.
Several studies have centered on this anxiety in cancer
patients. Fellowes et al. (3) concluded in a systematic
review that aromatherapy massage conferred short-term
benefits on psychologic well being, with the effect on
anxiety supported by limited evidence and that effect
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properly cited.on physical symptoms might also occur. Corner et al. (4)
evaluated the use of massage and essential oils on the
well being of cancer patients. The results showed that
anxiety scores reduced significantly over time only for the
essential oil massage group. Concerning effectiveness for
pain, mobility, ability to work and communication with
family, the essential oil group performed better than the
control group. Wilkinson et al. (5) also evaluated
aromatherapy massage in palliative care in a randomized
control study involving full body aromatherapy massage
or carrier oil massage three times a week. For the aroma
group, significant improvements were found for physical,
psychologic, quality of life and severe physical and
psychologic subscales of the Rotterdam Symptom
Checklist (RSCL), pre- to post-test. For the massage
group, there were no differences in any RSCL subscales,
from the pre- to post-test. For the whole group and each
group, significant improvements in the State-Trait
Anxiety Inventory (STAI)-state were noted pre- to post-
test for each massage. Kohara et al. (6) also reported that
combined modality treatment consisting of aromather-
apy, soaking the feet and reflexology appears to be
effective for alleviating fatigue in terminally ill cancer
patients.
Few studies have examined the psychologic and
immunologic effects of aromatherapy on breast cancer
patients. Since immunologic activity is a critical factor in
determining a patient’s prognosis, it is very important to
examine the effect of aromatherapy on immunologic
activity. Therefore, in the present study, we examined
the psychologic and immunologic parameters of
aromatherapy massage for breast cancer patients.
Methods
Subjects
This study was performed between 2003 and 2005.
The subjects were selected according to the following
criteria:
(i) Inclusion criteria
(a) patients with breast cancer
(b) subjects aged 20–70-years old
(c) more than 1 month after surgery, chemotherapy or
irradiation
(d) indifferent from stage of cancer and
(e) possibility of hormonal therapy
(ii) Exclusion criteria
(a) patients with recurrence of cancer
(b) patients with marked edema
This study was conducted after obtaining approval from
the Ethics Committee of Kyoto Prefectural University of
Medicine. We gave detailed explanations on the project
to each subject and all subjects signed informed consent
forms prior to participating. Fourteen patients were
entered into the present study, aged 45–58 years, stage
1–4, from 6 months to over 3 years post-operation.
Recurrence was observed in two patients. Therefore,
these two were excluded from this study. All patients had
received chemotherapy and/or hormonal treatment,
although more than 1 month had passed since the
completion of chemotherapy (Table 1).
Study Design
We designed this study as an open semi-comparative
trial, which means that the 1 month period before
aromatherapy massage was a waiting control period.
We compared the parameters in this period with those
during the aromatherapy massage sessions and 1 month
after the completion of aromatherapy.
Carrier Oil and Essential Oils
Jojoba oil was purchased from Meadows (Canterbury,
UK). Sweet orange oil (Citrus aurantium) (Lot
No.LF3190567), Lavender oil (Lavandula angustifolia)
(Lot No. LF3190559) and Sandalwood oil (Santalum
album) (Lot No. LF3160489) were purchased from
Laboratoire Sanoflore (Gigore-et-Lozeron, France).
Psychologic Tests
We used the Hospital Anxiety and Depression Scale
(HADS) (7), STAI (8) and Profile of Mood State
(POMS) (9) for evaluation of the psychologic response.
The subjects filled out the forms for psychologic tests
(STAI and POMS) 1 month before aromatherapy
massage, immediately before and after the first,
fifth and eighth massage, and 1 month after massage.
The 1-month period before aromatherapy massage was
designated as a waiting control period. We used State
anxiety of STAI for determination of short-term effect of
aromatherapy massage. We used Trait anxiety of STAI
and POMS for the determination of long-term effect.
Table 1. Profile of breast cancer patients
Age 40–49-years old 50–59-years old
39
Stage I IIA & B Unknown
372
Surgical
intervention
BCR Mastectomy
84
Non-surgical
intervention
Chemotherapy
hormone
Chemotherapy
irradiation
Hormone
615
BCR, breast conserving surgery.
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1 month before aromatherapy massage, immediately
before the first, fifth and eighth massage and 1 month
after massage. HADS was used for determination of
long-term effect.
Procedure of Aromatherapy Massage
The subjects received a 30min aromatherapy massage
twice a week for 4 weeks (eight times in total).
Each subject received the same standardized massage
performed on the anterior area of the neck and thorax,
back, shoulders, arms, hands and upper legs for  30min
by skilled therapists.
Methods for Immune Measurements
Peripheral blood was drawn 1 month before aromather-
apy massage, immediately before the first, fifth and
eighth massage, and 1 month after massage. Blood cell
counts including numbers and proportions of leukocytes
were examined at the Central Laboratory Unit of Kyoto
Prefectural University of Medicine. Heparinized blood
samples of 2ml were used to determine the levels of
various lymphocyte subsets. Mononuclear cells were
isolated by Ficoll-Paque
TM PLUS (Amersham
Biosciences AB, Sweden) gradient centrifugation.
Lymphocyte subsets were identified by FACS analysis
(FACS Caliber, Becton, Dickinson and Company,
Franklin Lakes, NJ, USA) using FITC (fluorescein-
isothiocyanate)-CD16, PE (Phycoerythrin)-CD8, FITC-
CD4 antibodies (Becton, Dickinson and Company), CFS
(carboxyfluorescein succinimidylester)-CXCR3 antibodies
(DAKO A/S, Glostrup, Denmark) and PE-CCR4 (BD
Bioscience Pharmingen, San Jose, CA, USA).
Statistical Analysis
We examined differences in data between pre- and post-
massage sessions using the paired t-test. Temporal
changes in the scores of psychologic tests were examined
using the repeated measures ANOVA and Bonferroni
test. All statistical analyses were conducted using SPSS
software (Advanced Models 14.0J). A P-value50.05 was
considered significant.
Results
Anxiolytic and Anti-Depressive Effects
We assessed psychologic responses to treatment as
changes in anxiety and depression using HADS and
STAI (Fig. 1). In HADS, we tested the anxiety level
1 month before aromatherapy massage, immediately
before the first, fifth and eighth massage and 1 month
after massage. The results showed a significant difference
among whole periods, tested by repeated measures
ANOVA (P50.01). It was found that there were no
significant changes in anxiety or depression in HADS
during the waiting control period and the anxiety level
gradually reduced over time and that there were
significant differences between anxiety scores 1 month
before massage and immediately before the eighth
massage (P50.05) and between those tested 1 month
before and after massage (P50.01, by paired t-test and
P50.05, by Bonferroni test). However, there were no
significant differences observed in the depression scores,
by repeated measures ANOVA. Also, in the total HADS
score, there were significant differences among whole
periods and between those of 1 month before massage
and immediately before the eighth massage P50.01, by
paired t-test and P50.05 by Bonferroni test), and
between those of 1 month before and after massage
(P50.01 by paired t-test and Bonferroni test), as in the
anxiety scores.
In STAI, trait anxiety was gradually reduced and there
were significant differences among whole periods,
between the scores tested 1 month before massage and
immediately before the first massage (P50.05) and
between those tested 1 month before and after the first
massage (P50.05). State anxiety scores from STAI were
significantly reduced after aromatherapy massage.
Namely, there were significant differences among whole
periods and between the scores tested 1 month before
massage and immediately before the fifth massage and
between those tested immediately before and after the
first, fifth and eighth massages. However, there was no
significant difference in the waiting control period.
Changes of Mood State
Next, we examined the POMS using the POMS test. The
results showed that aggression-hostility and fatigue were
gradually reduced, but there were no significant differ-
ences in anger-hostility between scores tested 1 month
before massage and immediately before the fifth massage
and between scores tested 1 month before massage and
immediately before the eighth massage. A significant
difference was observed in aggression-hostility between
scores tested 1 month before and after massage
(P50.05).
Immunologic Measures
There were no significant differences in the number of
leukocytes, and neutrophils, lymphocyte, CD4-positive
lymphocytes and CD8-positive lymphocytes which are
types of leukocytes, in the waiting control period.
Leukocytes and lymphocyte increased significantly
after the eighth aromatherapy massage session, as
compared with those before the eighth massage (Fig. 2).
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increase after the first and eighth aromatherapy massage,
compared with those before the first and eighth massage.
CD4-CCR4-positive lymphocytes also tend to increase by
the first aromatherapy session.
Discussion
It is well known that aromatherapy is a representative
complementary therapy to reduce anxiety. In our
investigation, we gave aromatherapy massage to breast
cancer patients to see if and how it ameliorated
anxiety and depression and enhanced the immunologic
state.
First, we examined psychologic responses to aromather-
apy massage using STAI, POMS and HADS. State
anxiety scores of STAI are adequate to determine the
short-term effects of aromatherapy. Especially, in STAI,
state anxiety scores significantly decreased after each
aromatherapy massage session. This result is in accord-
ance with those of our previous study (1) and those of
Wilkinson et al. (5).
Figure 1. Psychologic effects of aromatherapy massage on breast cancer patients. (A) The subjects filled out the forms of HADS test 1 month before
aromatherapy massage, immediately before the first massage fifth massage and eighth massage and 1 month after massage. (B) The subjects filled out
the forms for psychologic tests (STAI) 1 month before aromatherapy massage, immediately before and after the first massage, fifth massage and
eighth massage and 1 month after massage. (C) The subjects filled out the forms of POMS test 1 month before aromatherapy massage, immediately
before the first, fifth and eighth massage and 1 month after massage. *P50.05, **P50.01, NS: not significant: not done, by repeated measures
ANOVA or by paired t-test. *P50.05, (**)P50.01, by Bonferroni test.
126 Aromatherapy and breast cancerOn the other hand, trait anxiety using STAI and
HADS, which are appropriate for the determination of
long-term effects, gradually reduced over the sessions.
That is, there was a significant decrease in trait anxiety
scores between 1 month before and after massage.,
HADS also showed that the anxiety gradually reduced
over time, while there were no significant differences in
the depression scores. Coinciding with our results, Corner
et al. (4) also reported that aromatherapy massage
significantly reduced anxiety. Although other investiga-
tions (10–13) did not find that aromatherapy had an
anxiolytic effect in patients with cancer, we found that
aromatherapy massage had both short- and long-term
effects on anxiety reduction in breast cancer patients.
Immunologic, CD16-positive lymphocytes (natural
killer cells) were reduced significantly after aromatherapy
massage and there was a significant difference between
the numbers immediately before the first and eighth
massage. However, CD4-CXCR3-positive lymphocytes
(type 1 helper T cells) increased significantly after the
eighth aromatherapy massage, as compared with before
the eighth massage. CD4-CCR4-positive lymphocytes
(type 2 helper T cells) also increased significantly by
aromatherapy sessions. Although it is hard to interpret
these results theoretically, it is possible that aromather-
apy massage affects the immune system. In our previous
study of healthy subjects, CD8-positive and CD16-
positive lymphocytes increased significantly after a
30min aromatherapy session (1). The behavior of
CD16-positive lymphocytes, however, was different
from that of this investigation and we are as yet unable
to explain this difference.
No significant changes in the waiting control period
and significant decreases of anxiety both in the short-
term and long-term show that aromatherapy massage
holds promise as an effective therapy for breast cancer
patients. Further investigations with an increased sample
size and improved study design, including a control
group, are required to confirm our results. To do this, it
will be important to find a therapy suitable for the
control.
Outside psychologic therapies, anxiolytic drugs
and anti-depressants, conventional medicine offers no
effective interventions to reduce anxiety concerning
recurrence and/or metastasis. Our results suggest that
aromatherapy massage is a viable complementary therapy
that significantly reduces anxiety in breast cancer
patients.
Figure 2. Immunologic effects of aromatherapy massage on breast cancer patients. Peripheral blood was drawn 1 month before
aromatherapy massage, immediately before the first, fifth and eighth massage, and 1 month after massage. And blood cell
counts including numbers and proportions of leukocytes were examined. Lymphocyte subsets were identified by FACS analysis. *P50.05,
NS: not significant.
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